Esperion Therapeutics | 8-K:重大事件
Esperion Therapeutics | 4:持股变动声明-高管 Warren Eric
Esperion Therapeutics | 144:拟议出售证券
Esperion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Two Seas Capital LP(3.3%),Two Seas Capital GP LLC(3.3%)等
Esperion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(6.64%)
Esperion Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(7.3%)
Esperion Therapeutics | 10-Q:2024财年三季报
Esperion Therapeutics | 8-K:Esperion公布2024年第三季度财务业绩并提供业务最新情况
Esperion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(6.64%)
Esperion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(6.64%)
Esperion Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(7.3%)
Esperion Therapeutics | 4:持股变动声明-高管 Warren Eric
Esperion Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Millennium Management LLC(1.7%),Millennium Group Management LLC(1.7%)等
Esperion Therapeutics | 144:拟议出售证券
Esperion Therapeutics | 4:持股变动声明-高管 Koenig Sheldon L.
Esperion Therapeutics | 4:持股变动声明-高管 Warren Eric
Esperion Therapeutics | 144:拟议出售证券
Esperion Therapeutics | 144:拟议出售证券
Esperion Therapeutics | 144:拟议出售证券
Esperion Therapeutics | 4:持股变动声明-高管 Warren Eric